An independent, not-for-profit projectFree knowledge. Better questions.
peptide.cyWhy we exist ↗
QUALITY GUIDE

What better purification should prove

Reward measured outcomes, not an expensive-sounding manufacturing story.

What it is

Peptide synthesis can leave related sequences, reagents, solvents and counterions. Purification separates the desired material, but each process has specific capabilities and limitations.

What the evidence tells us

Preparative chromatography is a manufacturing step; analytical chromatography evaluates a sample. Evidence of solvent control, elemental impurities and related-species characterization adds information a purity headline misses.

What remains uncertain

Price and claims of multiple purification rounds are not proof of a cleaner product. Residual-solvent limits depend on the substance and exposure. Use the applicable specification and validated method.

Read the finding, not just the headline.

Check the population, product, route, comparator and outcome. A laboratory mechanism is not a proven health benefit, and a supplier’s certificate is not a clinical study.

Follow the evidence

Sources accessed 10 September 2026. Vendor claims and vendor-hosted reports are identified as such.

  1. FDA / ICH: residual solvents ↗
  2. GenScript: peptide quality control ↗
Suggest a correction or missing study →

Keep your curiosity going.

Quality guide⟐Start here

99% pure. But pure of what? ↗

The number on the label is only one part of the evidence.

Read the evidence →
Quality guide⌬Practical checklist

How to read a peptide COA ↗

Follow the sample, the method and the evidence back to their source.

Read the evidence →
Quality guide∿Two different questions

Endotoxins ≠ sterility ↗

A product can pass one test and fail the other.

Read the evidence →

Put the evidence side by side.